| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harmony Biosciences Holdings, Inc. (HRMY) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. HRMY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $759.9K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | Nielsen Jack76 | Director | Sell | 16,181 | $50.08 | $810,373.30 | -0.2% | -13.6% | -14.7% | |
| Mar 16, 2022 | Jacobs John C53 | President, CEO | Sale+OE | 15,000 | $45.32 | $679,821.00 | -100% | -6.8% | -14.2% | |
| Mar 14, 2022 | Jacobs John C53 | President, CEO | Sale+OE | 25,000 | $42.39 | $1,059,771.96 | -65.0% | +4.9% | -2.3% | |
| Mar 11, 2022 | Wicki Andreas71 | Director | Sell | 285,587 | $45.24 | $12,919,670.40 | -2.5% | +6.2% | -5.9% | |
| Mar 3, 2022 | Wicki Andreas71 | Director | Sell | 596,428 | $40.62 | $24,227,112.28 | -4.5% | +2.8% | +3.8% | |
| Mar 1, 2022 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 14,910 | $40.01 | $596,610.73 | -100% | +8.8% | +6.9% | |
| Feb 17, 2022 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 8,518 | $40.03 | $341,014.72 | -100% | +1.7% | +25.7% | |
| Jan 6, 2022 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 6,125 | $40.37 | $247,257.80 | -54.3% | +22.1% | +32.6% | |
| Jan 4, 2022 | Jacobs John C53 | President, CEO | Sale+OE | 28,700 | $45.16 | $1,295,985.26 | -100% | +15.2% | +24.2% | |
| Dec 27, 2021 | Jacobs John C53 | President, CEO | Sale+OE | 1,300 | $45.03 | $58,538.48 | -100% | +16.1% | +26.0% |